CHIC Advisers provide independent, science- and policy-based guidance to advance HPV vaccination programs and cervical cancer elimination globally. Our advisers facilitate dialogue between country decision-makers and global stakeholders, ensuring CHIC initiatives reflect diverse regional perspectives and remain relevant to resource-constrained settings.
CHIC Advisers serve on one of two complementary tracks:
Symposium Planning Committee Track – Advising on CHIC’s annual regional symposia, including scientific topics, speakers, formats, and outputs such as publications and recommendations.
Global Technical Advocacy Track – Shaping CHIC’s technical advocacy efforts, developing policy briefs and consensus statements, and engaging with global partners and coalitions on emerging HPV vaccination topics.
Symposium Planning Committee Track
Dr. Edina Amponsah-Dacosta
Research Officer and Evidence-Informed Decision-Making Specialist, Vaccines for Africa Initiative (VACFA), University of Cape Town, South Africa
Prof Dang Duc Anh
National Institute of Hygiene and Epidemiology (NIHE), Hanoi, Vietnam
Prof Deborah Watson Jones
Professor of Clinical Epidemiology & International Health, London School of Hygiene and Tropical Medicine (LSHTM); based at the Mwanza Intervention Trials Unit (MITU), Tanzania
Dr. Emily Kobyashi
Director of Vaccine Programmes, Gavi, the Vaccine Alliance, Geneva, Switzerland
Dr. Nelly Rwamba Mugo
Senior Principal Clinical Research Scientist, Kenya Medical Research Institute (KEMRI); Research Associate Professor, Department of Global Health, University of Washington, USA
Dr. Andreas Ateke Njoh
Expanded Program on Immunization (EPI), Cameroon Ministry of Public Health, Yaoundé, Cameroon
Dr. Safdar Nosheen
HPV-focal person at World Health Organization Africa(WHO Afro)
Prof Dr. Silvia Sanjose
Epidemiologist; formerly at the Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain
Dr. Zainab Shinkafi Bagudu
Founder/CEO, Medicaid Cancer Foundation (MCF); President-Elect, Union for International Cancer Control (UICC); Chairperson, First Ladies Against Cancer (FLAC) — Nigeria
Prof Margaret Stanley
Professor Emerita of Epithelial Biology, Affiliated Lecturer, Department of Pathology, University of Cambridge, UK; Past-President, International Papillomavirus Society (IPVS)
Sarah Wanyoike
Vaccine Preventable Diseases Team Lead, WHO Inter-Country Support Team for Eastern and Southern Africa
Global Technical Advocacy Track
Dr. Iacopo Baussano
Team Leader, Public Health Decision Science Team, Early Detection, Prevention, and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France
Prof. Neerja Bhatla
Former Head, Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi; Former President, International Federation of Gynaecology and Obstetrics (FIGO); currently leads research at AIIMS/National Cancer Institute, Jhajjar
Dr. Julia Brotherton
Professor of Cancer Prevention Policy and Implementation, Melbourne School of Population and Global Health, University of Melbourne; Professorial Fellow, National Centre for Immunisation Research and Surveillance (NCIRS)
Dr. Cathy Ndiaye
Director of HPV Vaccine Programs, PATH, Dakar, Senegal
Prof. You-Lin Qiao
Professor and Director, Department of Cancer Epidemiology, National Cancer Centre, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China